|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/09/22 QSAM Biosciences, Inc. 8-K:5,9 3/04/22 12:231K M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 33K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 11K 3: EX-99.1 Miscellaneous Exhibit HTML 12K 7: R1 Cover HTML 42K 10: XML IDEA XML File -- Filing Summary XML 12K 8: XML XBRL Instance -- form8-k_htm XML 14K 9: EXCEL IDEA Workbook of Financial Reports XLSX 6K 5: EX-101.LAB XBRL Labels -- qsam-20220304_lab XML 97K 6: EX-101.PRE XBRL Presentations -- qsam-20220304_pre XML 64K 4: EX-101.SCH XBRL Schema -- qsam-20220304 XSD 12K 11: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K 12: ZIP XBRL Zipped Folder -- 0001493152-22-006415-xbrl Zip 16K
EXHIBIT 3.1
CERTIFICATE OF AMENDMENT
OF the
Amended and Restated CERTIFICATE OF INCORPORATION
OF
QSAM Biosciences, inc.
* * * * *
QSAM Biosciences, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (“DGCL”), hereby certifies as follows:
1. This Certificate of Amendment (the “Certificate of Amendment”) amends the provisions of the Corporation’s Amended and Restated Certificate of Incorporation filed with the Secretary of State dated December 23, 2010, subsequently amended by that certain Certificate of Amendment dated November 18, 2015, and that certain Certificate of Amendment dated August 18, 2017, and that certain Certificate of Amendment dated September 4, 2020 (the “Certificate of Incorporation”).
2. Article XII of the Certificate of Incorporation is hereby amended and replaced in its entirety as follows:
“ARTICLE XII
ONE-FOR-FORTY REVERSE SPLIT
Effective as of 5:00 P.M. EST on March 9, 2022, each forty (40) shares of Common Stock issued and outstanding immediately prior to the aforesaid date and time shall, automatically and without any action on the part of the respective holders thereof, be combined and converted into one (1) share of Common Stock (the “Reverse Stock Split”), with all fractional shares that would otherwise result from such Reverse Stock Split being rounded up to the nearest whole share.”
3. The aforesaid amendment was duly adopted in accordance with the applicable provisions of Sections 228 and 242 of the General Corporation Law of the State of Delaware.
4. The aforesaid amendments shall be effective as of 5:00 P.M. EST on March 9, 2022, unless withdrawn by the Corporation prior to such time.
5. All other provisions of the Certificate of Incorporation, as amended, shall remain in full force and effect.
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed this 4th day of March, 2022.
| /s/ Douglas Baum | ||
| Douglas Baum, Chief Executive Officer and Director |
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/9/22 | |||
| For Period end: | 3/4/22 | 8-K | ||
| 9/4/20 | 8-K | |||
| 8/18/17 | 8-K | |||
| 11/18/15 | 8-K | |||
| 12/23/10 | 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/20/24 QSAM Biosciences, Inc. 10-K 12/31/23 55:7.4M M2 Compliance LLC/FA 3/30/23 QSAM Biosciences, Inc. 10-K 12/31/22 60:7.4M M2 Compliance LLC/FA 4/04/22 QSAM Biosciences, Inc. S-1/A 2:146K M2 Compliance LLC/FA 4/01/22 QSAM Biosciences, Inc. S-1/A 71:16M M2 Compliance LLC/FA 3/24/22 QSAM Biosciences, Inc. S-1/A 71:16M M2 Compliance LLC/FA 3/10/22 QSAM Biosciences, Inc. S-1/A 73:19M M2 Compliance LLC/FA |